
![]()
PROCLEIX® OPTIVA™ Front-End Pipetter
Overview (for non-US residents only)
The PROCLEIX® OPTIVA™ Front-End Pipetter (FEP) automates the labor-intensive pipetting of samples and target capture reagent for PROCLEIX® Assays, saving you time and speeding workflow. This easy-to-use bench-top instrument operates in a completely enclosed environment to enhance security and operator safety.
- Saves labor and time
- Flexible platform for pooling and assay pipetting
- Meets IVD directives for safety
- Easy to use sofware that guides users
Benefits
- Eliminates labor-intensive sample and target-capture pipetting steps, freeing up time for other work
- Automatically reads all barcodes, eliminating labor-intensive manual verification
- Performs both assay and pooling steps, reducing the number of instruments in the lab
- Easy to use, facilitating training and implementation
- Automated pipetting potentially reduces risk of repetitive stress injuries
About Novartis Vaccines

Novartis Vaccines is a leader in providing products to fight more than 20 vaccine-preventable viral and bacterial diseases. Novartis Vaccines is the division researching novel treatments.